Immunogenicity of therapeutic proteins: Clinical implications and future prospects

This publication has 66 references indexed in Scilit:

• Interferon Alfacon-1
  Drugs, 2001
• Towards a Quantitative Model of Immunogenicity: Counting Pathways in Sequence Space
  Journal of Theoretical Biology, 2000
• T-cell recognition of discrete regions of the thrombolytic drug streptokinase
  Clinical Science, 2000
• Biological and clinical significance of neutralizing and binding antibodies to interferon-alpha (IFN–α) during therapy for chronic hepatitis C
  Clinical and Experimental Immunology, 1994
• Interferon antibodies in patients with chronic hepatitic C virus infection treated with recombinant interferon alpha-2α
  Journal of Hepatology, 1994
• Phase I study of continuous-infusion soluble CD4 as a single agent and in combination with oral dideoxyinosine therapy in children with symptomatic human immunodeficiency virus infection
  The Journal of Pediatrics, 1992
• Recombinant interferon α-2A combined with prednisone in metastatic renal-cell carcinoma: Treatment results, serum interferon levels and the development of antibodies
  International Journal of Cancer, 1992
• Interferon antibodies may negate the antiviral effects of recombinant α-interferon treatment in patients with chronic hepatitis B virus infection
  Hepatology, 1990
• LEUCOCYTE-DERIVED INTERFERON-ALPHA IN PATIENTS WITH ANTIBODIES TO RECOMBINANT IFN-α2b
  The Lancet, 1988
• Clinical Experience with Somatonorm
  Acta Paediatrica, 1986